239 related articles for article (PubMed ID: 36380646)
41. Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.
Petraitiene R; Petraitis V; Bacher JD; Finkelman MA; Walsh TJ
Med Mycol; 2015 Aug; 53(6):558-68. PubMed ID: 26129890
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
[TBL] [Abstract][Full Text] [Related]
43. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
44. Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.
Dai Z; Cai M; Yao Y; Zhu J; Lin L; Fang L; Li Z; Yi H; Chen B; Liang X
Medicine (Baltimore); 2021 Apr; 100(14):e25233. PubMed ID: 33832082
[TBL] [Abstract][Full Text] [Related]
45. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
[TBL] [Abstract][Full Text] [Related]
46. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
Rose SR; Vallabhajosyula S; Velez MG; Fedorko DP; VanRaden MJ; Gea-Banacloche JC; Lionakis MS
J Infect; 2014 Sep; 69(3):278-83. PubMed ID: 24797077
[TBL] [Abstract][Full Text] [Related]
47. Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis-A pilot study.
Ajayababu A; Singh G; Meena VP; Upadhyay AD; Rana B; Sethi P; Prakash B; Singh A; Vyas S; Sinha S; Xess I; Wig N; Kabra SK; Ray A
Mycoses; 2024 Jan; 67(1):e13695. PubMed ID: 38282361
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
[TBL] [Abstract][Full Text] [Related]
49. COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.
Lackner N; Thomé C; Öfner D; Joannidis M; Mayerhöfer T; Arora R; Samardzic E; Posch W; Breitkopf R; Lass-Flörl C
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205848
[TBL] [Abstract][Full Text] [Related]
50. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
[TBL] [Abstract][Full Text] [Related]
51. Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis.
Román-Montes CM; Bojorges-Aguilar S; Díaz-Lomelí P; Cervantes-Sánchez A; Rangel-Cordero A; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-León A; González-Lara MF
Front Fungal Biol; 2022; 3():855914. PubMed ID: 37746186
[TBL] [Abstract][Full Text] [Related]
52. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
[TBL] [Abstract][Full Text] [Related]
53. Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort.
Versyck M; Zarrougui W; Lambiotte F; Elbeki N; Saint-Leger P
J Mycol Med; 2021 Jun; 31(2):101122. PubMed ID: 33621792
[TBL] [Abstract][Full Text] [Related]
54. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.
Zhou W; Li H; Zhang Y; Huang M; He Q; Li P; Zhang F; Shi Y; Su X
J Clin Microbiol; 2017 Jul; 55(7):2153-2161. PubMed ID: 28446576
[TBL] [Abstract][Full Text] [Related]
56. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
[TBL] [Abstract][Full Text] [Related]
57. [Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
Liu L; Li J; Dong H; Jiang L; Song H; Zhang S; Zhang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):331-335. PubMed ID: 30914095
[TBL] [Abstract][Full Text] [Related]
58. [Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis].
Deng J; Wu SY; Liu Y; Ma Y; Xie Y; Chen ZX; Dai ZQ; Deng JL; Kang M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):124-128. PubMed ID: 29737102
[TBL] [Abstract][Full Text] [Related]
59. Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance.
Weinbergerova B; Kabut T; Kocmanova I; Lengerova M; Pospisil Z; Kral Z; Mayer J
Sci Rep; 2020 Oct; 10(1):17963. PubMed ID: 33087853
[TBL] [Abstract][Full Text] [Related]
60. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]